BRAF and colorectal cancer: However, the ‘German evidence-based guideline for colorectal cancer’ (2019) acknowledges the positive results of the TRIBE study, but highlights that the small number of BRAF mutated patients included only allows for establishing treatment hypotheses [54–56].